Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment

References

• Connell P H. Clinical manifestations and treatment of amphetamine type of dependence. Journal of the American Medical Association 1966; 196: 718–723
   Web of Science ®Google Scholar
• Kramer J C, Fischman V S, Littlefield D C. Amphetamine abuse: pattern and effects of high doses taken intravenously. Journal of the American Medical Association 1967; 201: 305–309
   PubMed Web of Science ®Google Scholar
• Gorelick D A. Overview of pharmacologic treatment approaches for alcohol and other drug addiction: intoxication, withdrawal, and relapse prevention. Psychiatric Clinic of North America 1993; 16: 141–156
   PubMed Web of Science ®Google Scholar
• Gawin F H, Ellinwood E H, Jr. Cocaine and other stimulants: actions, abuse, and treatment. New England Journal of Medicine 1988; 318: 1173–1182
   PubMed Web of Science ®Google Scholar
• Ritz M, Kuhar M. Relationship between self-administration of amphetamine and monoamine receptors in the brain—comparison with cocaine. Journal of Pharmacology and Experimental Therapeutics 1989; 248: 1010–1018
   PubMed Web of Science ®Google Scholar
• Gunne L, Anggard E. Pharmacokinetic studies with amphetamine-relationship to neuropsychiatric disorders. Journal of Pharmacokinetics and Biopharmaceutics 1973; 1: 481–495
   Google Scholar
• Diagnostic and statistical manual for mental disorders, 4th ed. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• Dackis C A, Gold M S. Pharmacological approaches to cocaine addiction. Journal of Substance Abuse and Treatment 1985; 2: 139–145
   PubMedGoogle Scholar
• Rossetti Z L, Hmaidan Y, Gessa G L. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. European Journal of Pharmacology 1992; 221: 227–234
   PubMed Web of Science ®Google Scholar
• Ricaurte G A, Schuster C R, Seiden L S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Research 1980; 193: 153–163
   PubMed Web of Science ®Google Scholar
• Jaffe J H. Drug addiction and drug abuse. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed., A G Gilman, T W Rall, A S Nies, P Taylor. McGraw-Hill, New York 1990; 522–573
   Google Scholar
• Seiden L S, Sabol K E. Amphetamine: effects on catecholamine systems and behavior. Annual Review of Pharmacology and Toxicology 1993; 32: 639–677
   Google Scholar
• Nutt D J. Addiction: brain mechanisms and their treatment implications. Lancet 1996; 347: 31–36
   PubMed Web of Science ®Google Scholar
• Ceci A, Garattini S, Gobbi M, Mennini T. Effect of long term amineptine treatment on pre- and postsynaptic mechanisms in rat brain. Journal of Pharmacology 1986; 88: 269–275
   Google Scholar
• Ponzio F, Achilli G, Garattini S, Perego C, Sacchetti G, Algeri S. Amineptine: its effect on the dopaminergic system of rats. Journal of Pharmacy and Pharmacology 1986; 38: 301–303
   PubMed Web of Science ®Google Scholar
• Samanin R, Jori A, Bernasconi S, Morpugo E, Garattini S. Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amphetamine in the rat. Journal of Pharmacy and Pharmacology 1977; 29: 555–558
   PubMed Web of Science ®Google Scholar
• Srisurapanont M, Jarusuraisin N, Jittiwutikan J. Amphetamine withdrawal: I. Reliability, valididty and factor structure of a measure. Australian and New Zealand Journal of Psychiatry 1999; 33: 5–9
   PubMed Web of Science ®Google Scholar
• Guy W. ECDEU assessment manual for psychopharmacology, revised. National Institute of Mental Health, Rockville, MD 1976, DHEWPublication no. (ADM) 76–338
   Google Scholar
• Gawin F H, Kleber H D. Cocaine abuse treatment: open pilot trial with desipramine and lithium carbonate. Archives of General Psychiatry 1984; 41: 903–909
   PubMed Web of Science ®Google Scholar
• Tennant F S, Jr, Sagherian A A. Double-blind comparison of amantadine and bromocriptine from ambulatory withdrawal from cocaine dependence. Archives of Internal Medicine 1987; 147: 109–112
   PubMed Web of Science ®Google Scholar
• Kosten T R, Schumann B, Wright D, Carney M D, Gawin F H. A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. Journal of Clinical Psychiatry 1987; 48: 442–444
   PubMed Web of Science ®Google Scholar
• Johanson C, Schuster C R. Cocaine. Psychopharmacology: the fourth generation of progress, F E Bloom, D J Kupfer. Raven Press, New York 1995; 1685–1697
   Google Scholar
• Biondi F, Di Rubbo R, Faravelli C, Mannaioni P F. Chronic amineptine abuse. Biological Psychiatry 1990; 28: 1004–1006
   PubMed Web of Science ®Google Scholar
• Prieto J M, Gost A, Obiols J, Caycedo N. Amineptine dependence and schizophrenia. Biological Psychiatry 1994; 36: 266–268
   PubMed Web of Science ®Google Scholar